C4 Therapeutics
CCCC
CCCC
113 hedge funds and large institutions have $298M invested in C4 Therapeutics in 2022 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 39 increasing their positions, 34 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
26% less first-time investments, than exits
New positions opened: 26 | Existing positions closed: 35
67% less capital invested
Capital invested by funds: $905M → $298M (-$607M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
113
Holding in Top 10
–
Calls
$2.28M
Puts
$32K
Top Buyers
| 1 | +$31.1M | |
| 2 | +$29.7M | |
| 3 | +$4.01M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.59M |
| 5 |
Walleye Capital
New York
|
+$2.37M |
Top Sellers
| 1 | -$15.2M | |
| 2 | -$12.2M | |
| 3 | -$11.7M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$11.4M |
| 5 |
RI
RTW Investments
New York
|
-$10.8M |